FLT3 Tyrosine Kinase Inhibition Modulates PRC2 and Promotes Differentiation in Acute Myeloid Leukemia

The authors demonstrated that FLT3 inhibitors increased myeloid maturation with reduced stem/progenitor cell populations in murine fms-like tyrosine kinase 3 (FLT3-ITD) AML.